{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:00:53Z","timestamp":1773205253729,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41391-020-00272-6","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T15:03:52Z","timestamp":1597935832000},"page":"220-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A novel method for detection of exfoliated prostate cancer cells in urine by RNA in situ hybridization"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1821-8783","authenticated-orcid":false,"given":"Jillian N.","family":"Eskra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Rabizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Mangold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9807-7433","authenticated-orcid":false,"given":"W. Nathaniel","family":"Brennen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Yeater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4138-2186","authenticated-orcid":false,"given":"Kenneth J.","family":"Pienta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan W.","family":"Partin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian P.","family":"Pavlovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1414-473X","authenticated-orcid":false,"given":"Jun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"272_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41391-019-0127-4","volume":"22","author":"JN Eskra","year":"2019","unstructured":"Eskra JN, Rabizadeh D, Pavlovich CP, Catalona WJ, Luo J. Approaches to urinary detection of prostate cancer. Prostate Cancer Prostatic Dis. 2019;22:362\u201381.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"272_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ucl.2015.08.003","volume":"43","author":"JJ Tosoian","year":"2016","unstructured":"Tosoian JJ, Ross AE, Sokoll LJ, Partin AW, Pavlovich CP. Urinary biomarkers for prostate cancer. Urol Clin North Am. 2016;43:17\u201338.","journal-title":"Urol Clin North Am"},{"key":"272_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-2303.1994.tb00412.x","volume":"5","author":"M Rupp","year":"1994","unstructured":"Rupp M, O\u2019Hara B, McCullough L, Saxena S, Olchiewski J. Prostatic carcinoma cells in urine specimens. Cytopathology. 1994;5:164\u201370.","journal-title":"Cytopathology"},{"key":"272_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1210\/endo-30-1-107","volume":"30","author":"WW Scott","year":"1942","unstructured":"Scott WW, Huggins C. The acid phosphatase activity of human urine, an index of prostatic secretion. Endocrinology. 1942;30:107\u201312.","journal-title":"Endocrinology"},{"key":"272_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000475336","volume":"26","author":"J Breul","year":"1994","unstructured":"Breul J, Pickl U, Hartung R. Prostate-specific antigen in urine. Eur Urol. 1994;26:18\u201321.","journal-title":"Eur Urol"},{"key":"272_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0302-2838(03)00201-X","volume":"44","author":"D Hessels","year":"2003","unstructured":"Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol. 2003;44:8\u201315. discussion 15-16","journal-title":"Eur Urol"},{"key":"272_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrurol.2009.40","volume":"6","author":"D Hessels","year":"2009","unstructured":"Hessels D, Schalken JA. The use of PCA3 in the diagnosis of prostate cancer. Nat Rev Urol. 2009;6:255.","journal-title":"Nat Rev Urol"},{"key":"272_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1126\/science.101.2629.519","volume":"101","author":"GN Papanicolaou","year":"1945","unstructured":"Papanicolaou GN, Marshall VF. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science. 1945;101:519\u201320.","journal-title":"Science"},{"key":"272_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0090-4295(83)90170-X","volume":"21","author":"R Sharifi","year":"1983","unstructured":"Sharifi R, Shaw M, Ray V, Rhee H, Nagubadi S, Guinan P. Evaluation of cytologic techniques for diagnosis of prostate cancer. Urology. 1983;21:417\u201320.","journal-title":"Urology"},{"key":"272_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.humpath.2009.01.004","volume":"40","author":"K Fujita","year":"2009","unstructured":"Fujita K, Pavlovich CP, Netto GJ, Konishi Y, Isaacs WB, Ali S, et al. Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology. Hum Pathol. 2009;40:924\u201333.","journal-title":"Hum Pathol"},{"key":"272_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/dc.2840040406","volume":"4","author":"VA Varma","year":"1988","unstructured":"Varma VA, Fekete PS, Franks MJ, Walther MM. Cytologic features of prostatic adenocarcinoma in urine: a clinicopathologic and immunocytochemical study. Diagn Cytopathol. 1988;4:300\u20135.","journal-title":"Diagn Cytopathol"},{"key":"272_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/pros.22981","volume":"75","author":"KP Nickens","year":"2015","unstructured":"Nickens KP, Ali A, Scoggin T, Tan SH, Ravindranath L, McLeod DG, et al. Prostate cancer marker panel with single cell sensitivity in urine. Prostate. 2015;75:969\u201375.","journal-title":"Prostate"},{"key":"272_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.eururo.2017.08.009","volume":"73","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Sharp A, Anderson CM, Silberstein JL, Taylor M, Lu C, et al. Novel junction-specific and quantifiable in situ detection of AR-V7 and its clinical correlates in metastatic castration-resistant prostate cancer. Eur Urol. 2018;73:727\u201335.","journal-title":"Eur Urol"},{"key":"272_CR14","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1242\/jcs.00633","volume":"116","author":"JM Levsky","year":"2003","unstructured":"Levsky JM, Singer RH. Fluorescence in situ hybridization: past, present and future. J Cell Sci. 2003;116:2833\u20138.","journal-title":"J Cell Sci"},{"key":"272_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz S, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969\u201374.","journal-title":"JAMA"},{"key":"272_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","volume":"271","author":"JI Epstein","year":"1994","unstructured":"Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271:368\u201374.","journal-title":"JAMA"},{"key":"272_CR17","doi-asserted-by":"publisher","first-page":"46710","DOI":"10.18632\/oncotarget.17362","volume":"8","author":"WN Brennen","year":"2017","unstructured":"Brennen WN, Zhang B, Kulac I, Kisteman LN, Antony L, Wang H, et al. Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate. Oncotarget. 2017;8:46710\u201327.","journal-title":"Oncotarget"},{"key":"272_CR18","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1007\/s12035-017-0834-6","volume":"55","author":"L Erben","year":"2018","unstructured":"Erben L, He MX, Laeremans A, Park E, Buonanno A. A novel ultrasensitive in situ hybridization approach to detect short sequences and splice variants with cellular resolution. Mol Neurobiol. 2018;55:6169\u201381.","journal-title":"Mol Neurobiol"},{"key":"272_CR19","doi-asserted-by":"publisher","first-page":"e2005970","DOI":"10.1371\/journal.pbio.2005970","volume":"16","author":"C McQuin","year":"2018","unstructured":"McQuin C, Goodman A, Chernyshev V, Kamentsky L, Cimini BA, Karhohs KW, et al. CellProfiler 3.0: Next-generation image processing for biology. PLOS Biol. 2018;16:e2005970.","journal-title":"PLOS Biol"},{"key":"272_CR20","first-page":"5975","volume":"59","author":"MJ Bussemakers","year":"1999","unstructured":"Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999;59:5975\u20139.","journal-title":"Cancer Res"},{"key":"272_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/PAS.0b013e3181e6cbf3","volume":"34","author":"B Gurel","year":"2010","unstructured":"Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Goggins M, et al. NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol. 2010;34:1097\u2013105.","journal-title":"Am J Surg Pathol"},{"key":"272_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41585-018-0119-5","volume":"16","author":"EE van der Toom","year":"2019","unstructured":"van der Toom EE, Axelrod HD, de la Rosette JJ, de Reijke TM, Pienta KJ, Valkenburg KC. Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies. Nat Rev Urol. 2019;16:7\u201322.","journal-title":"Nat Rev Urol"},{"key":"272_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/pros.1055","volume":"47","author":"XF Liu","year":"2001","unstructured":"Liu XF, Olsson P, Wolfgang CD, Bera TK, Duray P, Lee B, et al. PRAC: A novel small nuclear protein that is specifically expressed in human prostate and colon. Prostate. 2001;47:125\u201331.","journal-title":"Prostate"},{"key":"272_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2010.10.019","volume":"301","author":"JR Day","year":"2011","unstructured":"Day JR, Jost M, Reynolds MA, Groskopf J, Rittenhouse H. PCA3: from basic molecular science to the clinical lab. Cancer Lett. 2011;301:1\u20136.","journal-title":"Cancer Lett"},{"key":"272_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1158\/0008-5472.CAN-07-3224","volume":"68","author":"B Laxman","year":"2008","unstructured":"Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res. 2008;68:645\u20139.","journal-title":"Cancer Res"},{"key":"272_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.eururo.2015.04.039","volume":"70","author":"SA Tomlins","year":"2016","unstructured":"Tomlins SA, Day JR, Lonigro RJ, Hovelson DH, Siddiqui J, Kunju LP, et al. Urine TMPRSS2:ERG plus PCA3 for individualized prostate cancer risk assessment. Eur Urol. 2016;70:45\u201353.","journal-title":"Eur Urol"},{"key":"272_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1515\/cclm-2015-0599","volume":"54","author":"RJ Hendriks","year":"2016","unstructured":"Hendriks RJ, Dijkstra S, Jannink SA, Steffens MG, van Oort IM, Mulders PFA, et al. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes. Clin Chem Lab Med. 2016;54:483.","journal-title":"Clin Chem Lab Med"},{"key":"272_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0090-4295(98)00278-7","volume":"52","author":"SD Sweat","year":"1998","unstructured":"Sweat SD, Pacelli A, Murphy GP, Bostwick DG. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology. 1998;52:637\u201340.","journal-title":"Urology"},{"key":"272_CR29","first-page":"2461","volume":"58","author":"AC Croce","year":"2014","unstructured":"Croce AC, Bottiroli G. Autofluorescence spectroscopy and imaging: a tool for biomedical research and diagnosis. Eur J Histochem. 2014;58:2461\u20132461.","journal-title":"Eur J Histochem"},{"key":"272_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2012;14:22\u201329.","journal-title":"J Mol Diagn"},{"key":"272_CR31","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","volume":"179","author":"IL Deras","year":"2008","unstructured":"Deras IL, Aubin SM, Blase A, Day JR, Koo S, Partin AW, et al. PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol. 2008;179:1587\u201392.","journal-title":"J Urol"},{"key":"272_CR32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","volume":"69","author":"LS Marks","year":"2007","unstructured":"Marks LS, Fradet Y, Deras IL, Blase A, Mathis J, Aubin SM, et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology. 2007;69:532\u20135.","journal-title":"Urology"},{"key":"272_CR33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","volume":"52","author":"J Groskopf","year":"2006","unstructured":"Groskopf J, Aubin SMJ, Deras IL, Blase A, Bodrug S, Clark C, et al. APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem. 2006;52:1089\u201395.","journal-title":"Clin Chem"},{"key":"272_CR34","doi-asserted-by":"publisher","first-page":"50804","DOI":"10.18632\/oncotarget.15133","volume":"8","author":"M Alshalalfa","year":"2017","unstructured":"Alshalalfa M, Verhaegh GW, Gibb EA, Santiago-Jimenez M, Erho N, Jordan J, et al. Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients. Oncotarget. 2017;8:50804\u201313.","journal-title":"Oncotarget"},{"key":"272_CR35","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1200\/JCO.2013.52.8505","volume":"32","author":"JT Wei","year":"2014","unstructured":"Wei JT, Feng Z, Partin AW, Brown E, Thompson I, Sokoll L, et al. Can urinary PCA3 supplement PSA in the early detection of prostate cancer? J Clin Oncol. 2014;32:4066\u201372.","journal-title":"J Clin Oncol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-020-00272-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-020-00272-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-020-00272-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T23:08:49Z","timestamp":1629414529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-020-00272-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["272"],"URL":"https:\/\/doi.org\/10.1038\/s41391-020-00272-6","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The Johns Hopkins University has filed a patent application in which 4 co-authors were listed as inventors (JNE, WBI, CPP, JL).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}